ANANDRON Side Effects

6219993-5 | Gynaecomastia
on May 29, 2009 Male patient from FRANCE , 88 years of age, was treated with Anandron (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia. Anandron dosage: . During the same period patient was treated with MOTILIUM (View Motilium Review and Motilium Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), MODOPAR (View Modopar Review and Modopar Label ), ATHYMIL (View Athymil Review and Athymil Label ), OGASTORO (View Ogastoro Review and Ogastoro Label ), SERESTA (View Seresta Review and Seresta Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), TOPALOIC (View Topaloic Review and Topaloic Label ). Patient was hospitalized.

6182962-8 | Gynaecomastia
Patient was taking Anandron (View Usage). Patient had the following side effects: gynaecomastia on Apr 29, 2009 from FRANCE Additional patient health information: Male patient , 80 years of age, . Anandron dosage: . Patient was hospitalized.

5942148-6 | Back Pain, Dyspnoea, Hepatitis Cholestatic, Liver Injury
Adverse event was reported on Oct 29, 2008 by a Male patient taking Anandron (View Usage) (Dosage: ) . Location: , 81 years of age, After Anandron was administered, patient had the following side effects: back pain (What is back pain?), dyspnoea, hepatitis cholestatic, liver injury. Patient was hospitalized.

5674825-9 | Condition Aggravated, Duodenal Ulcer, Gastrointestinal Haemorrhage, Interstitial Lung Disease, Renal Failure, Vascular Dementia
on Mar 13, 2008 Male patient from AUSTRALIA , 86 years of age, was diagnosed with depression (What is depression?), vascular dementia and was treated with Anandron (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, duodenal ulcer, gastrointestinal haemorrhage, interstitial lung disease, renal failure, vascular dementia. Anandron dosage: Dose: Unk. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRANYLCYPROMINE SULFATE (View Tranylcypromine Sulfate Review and Tranylcypromine Sulfate Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized and became disabled.


5342020-9 | Dyspnoea, Haemoptysis, Pneumonitis, Pyrexia
on May 29, 2007 Male patient from , 73 years of age, was treated with Anandron (View Usage). Patient had the following side effects: dyspnoea, haemoptysis, pneumonitis, pyrexia. Anandron dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), PARIET (View Pariet Review and Pariet Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), ELIGARD (View Eligard Review and Eligard Label ). Patient was hospitalized.

5305377-0 | Nausea, Vertigo
Patient was taking Anandron (View Usage). After Anandron was administered, patient had the following side effects: nausea (What is nausea?), vertigo on Apr 17, 2007 from Additional patient health information: Male patient , 83 years of age, was diagnosed with prostate cancer (What is prostate cancer?), diabetes mellitus and. Anandron dosage: . During the same period patient was treated with XATRAL /00975301/ (View Xatral /00975301/ Review and Xatral /00975301/ Label ), NOVONORM (View Novonorm Review and Novonorm Label ), PRITOR /01421801/ (View Pritor /01421801/ Review and Pritor /01421801/ Label ). Patient was hospitalized.

5098037-5 | Asthenia, Confusional State, Hypocalcaemia, Hypokalaemia, Malignant Neoplasm Progression
Adverse event was reported on Aug 30, 2006 by a Male patient taking Anandron (View Usage) (Dosage: ) was diagnosed with prostate cancer metastatic and. Location: , 80 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, hypocalcaemia, hypokalaemia, malignant neoplasm progression. During the same period patient was treated with CLASTOBAN (View Clastoban Review and Clastoban Label ), ENANTONE SLOW RELEASE (View Enantone - Slow Release Review and Enantone - Slow Release Label ).

5092957-3 | Interstitial Lung Disease, Respiratory Failure
on Jul 27, 2006 Male patient from , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Anandron (View Usage). Patient had the following side effects: interstitial lung disease, respiratory failure. Anandron dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), MICARDIS (View Micardis Review and Micardis Label ).

5072704-1 | Interstitial Lung Disease, Respiratory Failure
on Jul 27, 2006 Male patient from , 74 years of age, was diagnosed with prostate cancer (What is prostate cancer?) and was treated with Anandron (View Usage). After Anandron was administered, patient had the following side effects: interstitial lung disease, respiratory failure. Anandron dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), EUPANTOL (View Eupantol Review and Eupantol Label ), MICARDIS (View Micardis Review and Micardis Label ).

4851290-2 | Dysphonia, Fatigue, Lethargy, Muscle Twitching, Nervous System Disorder, Somnolence
Patient was taking Anandron (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, fatigue, lethargy, muscle twitching, nervous system disorder, somnolence on Nov 14, 2005 from AUSTRALIA Additional patient health information: Male patient , 64 years of age, . Anandron dosage: .

4569010-8 | Alveolitis Allergic, Chest X-ray Abnormal, Diabetes Mellitus, Dyspnoea
Adverse event was reported on Jan 21, 2005 by a Male patient taking Anandron (View Usage) (Dosage: ) was diagnosed with prostate cancer (What is prostate cancer?), respiratory tract infection and. Location: , 79 years of age, Patient had the following side effects: alveolitis allergic, chest x-ray abnormal, diabetes mellitus, dyspnoea. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), BUSERELIN (Dose: Unk) (View Buserelin Review and Buserelin Label ). Patient was hospitalized.

4563745-9 | Chest X-ray Abnormal, Lung Disorder, Respiratory Disorder
on Jan 21, 2005 Male patient from , 79 years of age, was diagnosed with prostate cancer (What is prostate cancer?), respiratory tract infection and was treated with Anandron (View Usage). After Anandron was administered, patient had the following side effects: chest x-ray abnormal, lung disorder, respiratory disorder. Anandron dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), BUSERELIN (Dose: Unk) (View Buserelin Review and Buserelin Label ). Patient was hospitalized.